Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Management should set up NCIB
View:
Post by Maolain1 on Oct 17, 2016 2:02pm

Management should set up NCIB

If the Company fundamentals are still viable from Management's perspective it seems like they should set up a Normal Course Issuer Bid and buy back stock at these levels.  Take the funds from the senior notes and invest in buying back the stock, since no acquisition/development would yield the type of returns in the short term as investing in the beaten down stock...that is of course if they truely beleive in the Company's prospects.  This would be a good signal to the market and shorts would cover hard, they might not even need to buy back a single share just the NCIB itself would prop the share price by double (maybe triple) digit %.
Comment by Lumberfeverlong on Oct 17, 2016 2:12pm
Fully agree.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities